We are pleased to see this litigation moving forward. Our firm continues to receive Actos lawsuit inquiries from long-term users of the drug who later went on to develop bladder cancer.
New York, New York (PRWEB) May 05, 2013
Actos lawsuits continue to move forward in a consolidated litigation now underway in U.S. District Court, Western District of Louisiana, Bernstein Liebhard LLP reports. According to a Minute Entry posted on the Court’s website, a Status Conference was convened in the Actos litigation on April 25th, where the status of discovery and the bellwether nomination process were discussed. The Court also scheduled the litigation’s next Status Conference for May 23,2013. (In re: Actos Product Liability Litigation, MDL No. 2299)
“We are pleased to see this litigation moving forward. Our firm continues to receive Actos lawsuit inquiries from long-term users of the drug who later went on to develop bladder cancer,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Actos bladder cancer.
Actos Bladder Cancer
Actos lawsuits have been mounting in state and federal courts since the U.S. Food & Drug Administration (FDA) ordered Takeda to add new warnings to the Actos label in June 2011, after a study found that long-term use of the drug increased the risk for bladder cancer.* According to Bloomberg.com, more than 1,200 Actos bladder cancer claims are pending in the Louisiana litigation. Additional Actos lawsuits have been filed in state litigations in California and Illinois. Court documents indicate that the first trial in the federal Actos litigation is scheduled to begin in January.**
Last month, the nation’s first Actos bladder cancer trial ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking the drug for four years. However, just days later, the judge overseeing the case granted Takeda Pharmaceuticals’ request to set aside the verdict, according to Bloomberg. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Long-term Actos users who have been diagnosed with bladder cancer may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about filing an Actos lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, contact the Firm today by calling (877) 779-1414.
- fda.gov/drugs/drugsafety/ucm259150.htm (June 15, 2011)
**bloomberg.com/news/2013-05-01/takeda-gets-6-5-million-diabetes-drug-verdict-thrown-out.html (May 1, 2013)
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP